ADE (antibody-dependent enhancement) due to COVID vaccine: "SARS-CoV-2 Vaccination and Protection Against Clinical Disease: A Retrospective Study, Bouches-du-Rhône District, Southern France, 2021"

by Paul Alexander

James Lyons-Weiler, a mentor of mines, shared this paper and I felt you needed to see it as the results were very troubling when you looked into the data

‘Among 161 patients considered as fully vaccinated, i.e., >14 days after the completion of the vaccinal scheme (one dose for Johnson and Johnson and two doses for Pfizer/BioNTech, Moderna and Sputnik vaccines), 10 (6.2%) required hospitalization and four (2.5%) died. Risks of complications increased with age in a nonlinear pattern, with a first breakpoint at 54, 33, and 53 years for death, transfer to ICU, and hospitalization, respectively.’

More deaths in the fully vaccinated than unvaccinated based on this data. The reported death rate in the “fully vaccinated” (2.5%) was higher than the partially vaccinated (1.1%) and unvaccinated (2%). Why?



FIGURE 1. Temporal distribution of the numbers of patients who experienced SARS-CoV-2 infection following vaccination, according to the delay between vaccination and infection diagnosis. The red and green curves indicate patients who received a first or second dose, respectively.